IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them

Patent No. EP2275132 (titled "Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them") was filed by Boehringer Ingelheim on Dec 28, 2006. The application was issued on Mar 3, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CEVA SANTE ANIMALEDec 2, 2021CABINET BECKER ET ASSOCIES
ELANCONov 22, 2021POTTER CLARKSON
LABORATORIOS HIPRAMar 4, 2021GRUNECKER PATENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2275132

BOEHRINGER INGELHEIM
Application Number
EP10174464A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Jan 29, 2021
Publication Date
Mar 3, 2021
External Links
Slate, Register , Google Patents